I’ve never really bought this “loose canon / anti-establishment” candidate schtick. It looks like yet another con-job on the masses….The question is, which con is being run?
It truly boggles the mind that we are living in a world where we are facing an election for the world’s most important spokesmodel and the candidates will be Donald Trump (narcissistic, serial bankrupt) and Hillary Clinton (known racketeer and influence peddler).…
Read More
In a $40 million dollar funding round at a lower share price (a.k.a “a down round”) Glassdoor CEO went on record to say “We view this as a slight up round” (I guess you can add diluting shares to inflate market cap to the alchemical bag of tricks in this wonderful New Economy). Still, with shares down 6.3% in this round, they are still clobbering their publicly traded Unicorn peers such as LinkedIn and Yelp.... Read More
They were working on a spinal chord treatment but their clinical trials have failed. Bay area biotech “StemCells” (I was surprised they didn’t “invest” in the .com version of their name) which was publicly traded will wind down operations. They are hoping to see what can be salvaged for investors and skirt a 100% loss. At their peak: $74 million market cap. Now, not so much. ($6 million) They also raised 32 million in two... Read More
